Evaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from Stroke

You will have to ask your doctor what this article states and how it will be used to get you to 100% recovery.
http://journal.frontiersin.org/article/10.3389/fnmol.2016.00034/abstract

Amanda J. Craig^1* and Gary D. Housley¹

• ¹Translational Neuroscience Facility & Department of Physiology, University of New South Wales, Australia

Stroke is a leading cause of death and disability, with a lack of treatments available to prevent cell death, regenerate damaged cells and pathways, or promote neurogenesis. The extended period of hours to weeks over which tissue damage continues to occur makes this disorder a candidate for gene therapy. This review highlights the development of gene therapy in the area of stroke, with the evolution of viral administration, in experimental stroke models, from pre-injury to clinically relevant timeframes of hours to days post-stroke. The putative therapeutic proteins being examined include anti-apoptotic, pro-survival, anti-inflammatory, and guidance proteins, targeting multiple pathways within the complex pathology, with promising results. The balance of findings from animal models suggests that gene therapy provides a viable translational platform for treatment of ischaemic brain injury arising from stroke.

Keywords: ischaemia, Viral vector, protein expression, aav, adeno, Herpes Simplex Virus, Lentivirus
Citation: Craig AJ and Housley GD (2016). Evaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from Stroke. Front. Mol. Neurosci. 9:34. doi: 10.3389/fnmol.2016.00034